← Back to Search

Heart Smart Program for Cardiovascular Disease (Heart Smart Trial)

N/A
Waitlist Available
Led By Stacey E Rosen, MD
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Heart Smart Trial Summary

This trial seeks to improve heart health in women with a 6-week program to help reduce risk factors for heart disease over a year. The program includes weekly didactic sessions and an online discussion group.

Eligible Conditions
  • Cardiovascular Risk

Heart Smart Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decreased Blood Pressure
Decreased Body Mass Index (BMI)
Decreased Low Density Lipoprotein Cholesterol (LDL-C)
+2 more
Secondary outcome measures
Decreased Depression Score
Decreased HbA1c
Decreased Psychosocial Stress
+1 more

Heart Smart Trial Design

1Treatment groups
Experimental Treatment
Group I: Heart Smart Interventional ProgramExperimental Treatment1 Intervention
Subjects participate in this 6-week intervention which include a weekly didactic session, with each week devoted to a different theme (food, exercise, etc). The intervention will follow the program outlined in the book "Heart Smart for Women: Six S. T. E. P. S. in Six Weeks to Heart-Healthy Living."

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
458 Previous Clinical Trials
470,887 Total Patients Enrolled
Stacey E Rosen, MDPrincipal InvestigatorNorthwell Health; Katz Women's Hospital at Long Island Jewish Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies for this trial available?

"According to clinicaltrials.gov the study is no longer recruiting patients, with its initial posting on 15th January 2020 and last update being December 7st 2021. However, 515 other studies are still open for enrolment."

Answered by AI
Recent research and studies
Journal of the American College of CardiologyJournal
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Arnett, Donna K., Roger S. Blumenthal, Michelle A. Albert, Andrew B. Buroker, Zachary D. Goldberger, Ellen J. Hahn, Cheryl Dennison Himmelfarb, et al.. 2019. “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary”. Journal of the American College of Cardiology. Elsevier BV. doi:10.1016/j.jacc.2019.03.009.
clinicaltrials.govStudy
Primary Prevention of Cardiovascular Disease Among Female Hospital Employees: The Heart Smart for Women Intervention
Stacey Rosen 2020. "Primary Prevention of Cardiovascular Disease Among Female Hospital Employees: The Heart Smart for Women Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04166097.
All > Cardiovascular
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top